Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - ROCKET PHARMACEUTICALS, INC. | d263529dex321.htm |
| EX-31.2 - EX-31.2 - ROCKET PHARMACEUTICALS, INC. | d263529dex312.htm |
| EX-31.1 - EX-31.1 - ROCKET PHARMACEUTICALS, INC. | d263529dex311.htm |
| 10-K - 10-K - ROCKET PHARMACEUTICALS, INC. | d263529d10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement (No. 333-204501) on Form S-8 of Inotek Pharmaceuticals Corporation of our report dated March 23, 2016, relating to our audits of the consolidated financial statements, which appear in this Annual Report on Form 10-K of Inotek Pharmaceuticals Corporation for the year ended December 31, 2015.
/s/ RSM US LLP
Boston, Massachusetts
March 23, 2016